IN-VITRO AND IN-VIVO EVALUATION IN DOGS AND PIGS OF A HYDROPHILIC MATRIX CONTAINING PROPYLTHIOURACIL

被引:25
作者
KABANDA, L
LEFEBVRE, RA
VANBREE, HJ
REMON, JP
机构
[1] STATE UNIV GHENT,SCH MED,HEYMANS INST PHARMACOL,B-9000 GHENT,BELGIUM
[2] STATE UNIV GHENT,FAC VET MED,DEPT MED IMAGING,B-9000 GHENT,BELGIUM
关键词
HYDROXYPROPYLMETHYLCELLULOSE; PROPYLTHIOURACIL; SUSTAINED RELEASE; IN VITRO RELEASE; BIOAVAILABILITY IN DOGS AND PIGS;
D O I
10.1023/A:1018982409661
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A hydrophilic matrix tablet containing 300 mg of propylthiouracil was formulated with several types of hydroxypropylmethylcellulose. The influence of polymer and drug granule particle size, polymer concentration, crystallinity and geometry of the polymer particles, the polymer incorporation outside or inside the granule, addition of a filler and tablet hardness were studied. Polymer concentration, polymer particle size and geometry, filler addition and type of the filler used had a major influence on in vitro drug dissolution profiles. The bioavailability of propylthiouracil in dogs from the hydrophilic matrices investigated was low, because of the short gastro-intestinal transit times of the matrix tablets in the dogs. The matrix tablets reached the colon in fasted dogs within 2-3 hours after administration. The results indicated the poor predictability of bioavailability experiments in dogs with hydrophilic matrices. Although the bioavailability data in pigs seemed promising, a transit time study revealed a long stomach residence time of the matrix tablets in pigs. These data suggested that pigs are an inappropriate animal model for bioavailability studies of erodible matrix tablets.
引用
收藏
页码:1663 / 1668
页数:6
相关论文
共 22 条
[1]  
ABERNETHY DR, 1985, J PHARMACOL EXP THER, V234, P345
[2]  
ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
[3]  
BIALER M, 1988, ORAL SUSTAINED RELEA, P183
[4]   DOG AS A QUANTITATIVE MODEL FOR EVALUATION OF NONDISINTEGRATING SUSTAINED-RELEASE TABLETS [J].
CRESSMAN, WA ;
SUMNER, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (01) :132-&
[5]   INFLUENCE OF PHYSICOCHEMICAL PROPERTIES OF HYDROXYPROPYL METHYLCELLULOSE ON NAPROXEN RELEASE FROM SUSTAINED-RELEASE MATRIX TABLETS [J].
DAHL, TC ;
CALDERWOOD, T ;
BORMETH, A ;
TRIMBLE, K ;
PIEPMEIER, E .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (01) :1-10
[6]  
DRESSMAN JB, 1991, PHARM BIOEQUIVALENCE, V48, P235
[7]  
FORD J L, 1985, Journal of Pharmacy and Pharmacology, V37, p33P
[8]   IN VIVO PHARMACODYNAMIC EVALUATION OF ORAL DOSAGE FORMS BY WHOLE BODY LIQUID SCINTILLOMETRY [J].
HECHT, G ;
CHRISTIAN, JE ;
BANKER, GS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (07) :678-+
[9]   HYDROXYPROPYLMETHYLCELLULOSE SUSTAINED-RELEASE TECHNOLOGY [J].
HOGAN, JE .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (6-7) :975-999
[10]   GASTROINTESTINAL TRANSIT OF NONDISINTEGRATING, NONERODIBLE ORAL DOSAGE FORMS IN PIGS [J].
HOSSAIN, M ;
ABRAMOWITZ, W ;
WATROUS, BJ ;
SZPUNAR, GJ ;
AYRES, JW .
PHARMACEUTICAL RESEARCH, 1990, 7 (11) :1163-1166